Epilepsy Epidiolex denied for missing prior authorization by Cigna?
If the original prescription wasn't run through prior auth, the path is to submit a PA now with a medical-necessity letter — many plans then back-date approval to the date of service.
US health-plan appeal rights
Cite: Most US health plans have appeal rights under either the ACA, ERISA, or Medicare/Medicaid rules
Most US health plans are required by federal law to give you both an internal appeal (where the insurer reconsiders) and an external review (where an independent reviewer decides). The exact timelines and processes depend on what kind of plan you have — marketplace / employer group, self-funded, Medicare Advantage, or Medicaid MCO — but in every case there's a window after the denial during which you have the right to fight it.
What Cigna typically requires
Cigna's specific coverage criteria for epilepsy epidiolex are defined in its own published medical/coverage policy and the FDA-approved prescribing label. A successful appeal documents that your medical records satisfy each criterion those sources list — confirmed diagnosis, any required prior treatments (with dates and outcomes), and clinical severity. If the exact criteria weren't included with your denial, request them in writing; your appeal then maps each requirement to the matching fact in your chart.
The Cigna angle on Epilepsy Epidiolex
## Why Cigna Requires Prior Authorization for Epidiolex — and How to Navigate It
Epidiolex (cannabidiol) is an FDA-approved anti-seizure medication for rare, treatment-resistant epilepsy syndromes. Cigna requires prior authorization before covering Epidiolex, meaning the plan must review clinical documentation and confirm that the patient meets the criteria in its coverage policy before dispensing is covered. A prior-authorization denial is not a finding that the drug is inappropriate — it means the submitted documentation was insufficient or did not clearly satisfy each listed criterion. The appeal is your opportunity to provide a complete clinical picture.
## Why This Denial Is Appealable
Prior-authorization denials for Epidiolex are frequently reversed on appeal because they are documentation problems, not clinical ones. The most common gaps are: a missing specialist letter, incomplete prior medication history, or a diagnosis that was not linked clearly to an FDA-approved indication in the submitted paperwork. A complete, well-organized resubmission or appeal closes all of those gaps.
## Your Federal Appeal Rights
- Internal appeal: Under ACA §2719 and ERISA §503, you have the right to a full-and-fair internal review of the prior-authorization denial. File within the deadline in your denial letter.
- External review: If the internal appeal fails, you have approximately four months from the final adverse decision to request independent external review by a certified IRO.
- Expedited review: If the patient's seizures are frequent or severe and delay creates imminent clinical risk, request expedited review — Cigna must respond within 72 hours.
## Documentation to Gather
1. Confirmed epilepsy syndrome diagnosis: EEG reports, brain MRI results, genetic test results (where applicable), and clinical notes from a neurologist or epileptologist confirming the specific syndrome and its severity. 2. Prior anti-seizure medication history: A comprehensive chronological record of every ASM previously tried, including the timeframe of use, the clinical response, and the documented reason for discontinuation or inadequate response — this is the single most important document for Cigna's review. 3. Seizure frequency and severity documentation: A seizure log or chart summary demonstrating ongoing breakthrough events despite prior treatment. 4. Prescriber credentials: Confirmation that the prescriber is a neurologist or epileptologist, as Cigna's policy typically requires specialist prescribing for Epidiolex. 5. Medical-necessity letter: A detailed letter from the treating specialist that addresses each of Cigna's prior-authorization criteria explicitly, links the patient's clinical findings to each requirement, and states the expected treatment outcome.
## Criteria-Mapping Structure
Obtain Cigna's prior-authorization criteria for Epidiolex from Cigna's coverage policy portal. For each criterion listed:
| Cigna PA Criterion | Submitted Clinical Evidence | |---|---| | Confirmed covered diagnosis | [EEG report date, genetic test, specialist note] | | Age or eligibility characteristic | [Documented in chart] | | Number and type of prior ASMs | [Complete medication list with dates and outcomes] | | Prescribing specialist | [Neurologist/epileptologist credentials] | | Monitoring and follow-up plan | [Documented in prescriber letter] |
Submit this mapping table in your appeal cover letter so the Cigna reviewer can match each criterion to a specific document without having to search through the entire record.
Next steps
- Find the date on the denial letter — your appeal window starts there.
- Read your plan's Summary of Benefits and Coverage (SBC) for the specific deadlines.
- Request the insurer's claim file in writing — they must provide it.
- Submit your appeal in writing with new clinical evidence and a physician statement.
Get the letter drafted
DenialHelp drafts your appeal in 5 minutes — $40 list price, $30 for your first letter (use code SEO25). We cite the federal regs and the specific clinical evidence your plan responds to. Your physician signs and sends.
Start my appeal — $30 with code SEO25 →